» Articles » PMID: 15939761

ADAR2-mediated Editing of RNA Substrates in the Nucleolus is Inhibited by C/D Small Nucleolar RNAs

Overview
Journal J Cell Biol
Specialty Cell Biology
Date 2005 Jun 9
PMID 15939761
Citations 110
Authors
Affiliations
Soon will be listed here.
Abstract

Posttranscriptional, site-specific adenosine to inosine (A-to-I) base conversions, designated as RNA editing, play significant roles in generating diversity of gene expression. However, little is known about how and in which cellular compartments RNA editing is controlled. Interestingly, the two enzymes that catalyze RNA editing, adenosine deaminases that act on RNA (ADAR) 1 and 2, have recently been demonstrated to dynamically associate with the nucleolus. Moreover, we have identified a brain-specific small RNA, termed MBII-52, which was predicted to function as a nucleolar C/D RNA, thereby targeting an A-to-I editing site (C-site) within the 5-HT2C serotonin receptor pre-mRNA for 2'-O-methylation. Through the subcellular targeting of minigenes that contain natural editing sites, we show that ADAR2- but not ADAR1-mediated RNA editing occurs in the nucleolus. We also demonstrate that MBII-52 forms a bona fide small nucleolar ribonucleoprotein particle that specifically decreases the efficiency of RNA editing by ADAR2 at the targeted C-site. Our data are consistent with a model in which C/D small nucleolar RNA might play a role in the regulation of RNA editing.

Citing Articles

Small Nucleolar RNAs and the Brain: Growing Evidence Supporting Their Role in Psychiatric Disorders.

Salles J, Lin R, Turecki G Biol Psychiatry Glob Open Sci. 2025; 5(2):100415.

PMID: 39867567 PMC: 11758842. DOI: 10.1016/j.bpsgos.2024.100415.


snoRNA-facilitated protein secretion revealed by transcriptome-wide snoRNA target identification.

Liu B, Wu T, Miao B, Ji F, Liu S, Wang P Cell. 2024; 188(2):465-483.e22.

PMID: 39579764 PMC: 11761385. DOI: 10.1016/j.cell.2024.10.046.


Loss of ADAR1 protein induces changes in small RNA landscape in hepatocytes.

Roucova K, Vopalensky V, Masek T, Del Llano E, Provaznik J, Landry J RNA. 2024; 30(9):1164-1183.

PMID: 38844344 PMC: 11331409. DOI: 10.1261/rna.080097.124.


RNA modifications in cellular metabolism: implications for metabolism-targeted therapy and immunotherapy.

Liu W, Zheng S, Li T, Fei Y, Wang C, Zhang S Signal Transduct Target Ther. 2024; 9(1):70.

PMID: 38531882 PMC: 10966055. DOI: 10.1038/s41392-024-01777-5.


Lessons from discovery of true ADAR RNA editing sites in a human cell line.

Wang F, Cao H, Xia Q, Liu Z, Wang M, Gao F BMC Biol. 2023; 21(1):160.

PMID: 37468903 PMC: 10357658. DOI: 10.1186/s12915-023-01651-w.


References
1.
Rueter S, Dawson T, Emeson R . Regulation of alternative splicing by RNA editing. Nature. 1999; 399(6731):75-80. DOI: 10.1038/19992. View

2.
Keller W, Wolf J, Gerber A . Editing of messenger RNA precursors and of tRNAs by adenosine to inosine conversion. FEBS Lett. 1999; 452(1-2):71-6. DOI: 10.1016/s0014-5793(99)00590-6. View

3.
Easterwood L, Kamilar G, Beal P . Synthetic substrate analogs for the RNA-editing adenosine deaminase ADAR-2. Nucleic Acids Res. 1999; 27(14):2912-7. PMC: 148506. DOI: 10.1093/nar/27.14.2912. View

4.
Ganot P, Jady B, Bortolin M, Darzacq X, Kiss T . Nucleolar factors direct the 2'-O-ribose methylation and pseudouridylation of U6 spliceosomal RNA. Mol Cell Biol. 1999; 19(10):6906-17. PMC: 84686. DOI: 10.1128/MCB.19.10.6906. View

5.
Herrick-Davis K, Grinde E, Niswender C . Serotonin 5-HT2C receptor RNA editing alters receptor basal activity: implications for serotonergic signal transduction. J Neurochem. 1999; 73(4):1711-7. DOI: 10.1046/j.1471-4159.1999.731711.x. View